Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Shareholder vote
confidence 98%
filed 2026-05-28
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of COMPASS Pathways' 2026 Annual General Meeting held on May 27, 2026. The filing presents voting results for ten proposals including director elections (Justin Gover, Daphne Karydas, Kathleen Tregoning, Jeffrey Jonas), auditor appointments and ratifications, and advisory votes on executive compensation and remuneration reports. The material outcomes include the election of Kathleen Tregoning as a new director and the departure of Dr. Annalisa Jenkins after eight years of service. These shareholder votes are material to investors as they determine board composition and governance oversight.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-05-28
Item 3.02
CXApp Inc. issued 26.7 million shares of common stock to Avondale Capital under a Pre-Paid Purchase agreement at prices between $0.126 and $0.135 per share, relying on Section 4(a)(2) exemption for unregistered private placements. This is a classic dilutive equity issuance that would materially affect shareholder ownership and is properly disclosed under Item 3.02.
View raw filing on EDGAR →
8-K
M&A activity
confidence 94%
filed 2026-05-28
Item 3.02
Nextpower Inc. entered into an Equity Purchase Agreement to acquire 100% of Prevalon Energy LLC for up to $365 million in total consideration, comprising cash, stock (approximately $50 million issued under Section 4(a)(2)), and contingent payments. The transaction represents a material acquisition with integration of Prevalon's operations expected to generate combined company benefits.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-28
Item 5.07
This 8-K Item 5.07 discloses the complete voting results from Galaxy Digital's 2026 annual meeting of stockholders held on May 28, 2026. The filing reports results for four proposals: election of six directors (all elected), ratification of KPMG LLP as auditor, advisory approval of named executive officer compensation, and advisory vote on compensation vote frequency (determined to be annual). This is a textbook shareholder_vote_results disclosure with detailed vote tallies for each proposal.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-28
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of Perimeter Solutions' 2026 Annual Meeting of Stockholders held on May 28, 2026. The filing presents voting results for three proposals: election of eight directors, advisory approval of named executive officer compensation, and ratification of KPMG LLP as independent auditor. All three proposals passed with substantial majorities, making this a routine but material shareholder vote results disclosure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-28
Item 5.07
This 8-K Item 5.07 discloses the results of the Fund's 2026 annual meeting of shareholders held on May 21, 2026, specifically the election of six trustees. The filing presents detailed voting tallies for each trustee nominee (Kenneth Kencel, William Huffman, Stephen Potter, James Ritchie, Dee Dee Sklar, and Sarah Smith), showing votes for and withheld. This is a classic shareholder vote results disclosure required under Item 5.07, and trustee elections are material governance events affecting the Fund's board composition.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-28
Item 7.01
The filing discloses a quarterly update for Q1 2026 under Item 7.01 (Regulation FD Disclosures), which is a non-earnings-release periodic disclosure. While the update likely contains material financial or operational information relevant to investors in this closed-end fund, the 8-K itself does not constitute a formal earnings release (which would typically be Item 2.02) and the prose does not specify the content of the update. This is best classified as other_material since it represents a material periodic disclosure that does not fit the earnings_release category.
View raw filing on EDGAR →
8-K
Other material
confidence 45%
filed 2026-05-28
Item 7.01
This disclosure announces monthly distributions declared by a REIT across six share classes with a record date of May 31, 2026 and payment date of June 22, 2026. While distribution declarations are routine for REITs and typically disclosed via Regulation FD, this does not fit cleanly into the standard 8-K event taxonomy. The disclosure is material to shareholders as it affects cash flow and reinvestment decisions, but it is an ordinary course operational matter rather than an extraordinary event. The absence of a more specific event type (e.g., earnings_release, which typically involves comprehensive financial results) warrants classification as other_material.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-28
Item 5.07
This is a clear Item 5.07 disclosure of shareholder vote results from PHINIA Inc.'s May 22, 2026 annual meeting. The filing reports final voting tallies for three proposals: election of eight directors, advisory approval of named executive officer compensation, and ratification of Deloitte & Touche LLP as independent auditor. All three proposals passed with substantial majorities, making this a material disclosure of governance outcomes that investors rely upon to assess board composition and management accountability.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-05-28
Item 5.02
The filing discloses the appointment of Andrew Miller, Ph.D. to the Board of Directors on May 27, 2026, following unanimous Board approval. The disclosure includes detailed biographical information highlighting his extensive biotechnology leadership experience (founder of Karuna Therapeutics, former CEO, COO, and current board member of Kyverna Therapeutics), his compensation arrangements (initial and annual equity grants plus cash retainers), and committee assignments. This is a clear executive appointment event material to investors assessing board composition and governance.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-05-28
The filing discloses results of Sturm Ruger's 2026 Annual Meeting of Stockholders held on May 27, 2026, including voting outcomes for four proposals: election of nine directors, ratification of auditors (RSM US LLP), advisory vote on named executive officer compensation, and approval of a charter amendment to increase authorized common shares from 40 million to 60 million. Item 5.07 explicitly requires disclosure of shareholder vote results, and the charter amendment approval is material to investors as it affects the company's capital structure and future dilution potential.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-27
Item 7.01
The filing discloses a dividend announcement for Capital Southwest Corporation, a business development company (BDC), via press release furnished under Item 7.01 (Regulation FD Disclosure). While dividend announcements are routine for BDCs and REITs, they are material to investors as they directly affect shareholder returns and valuation. However, this does not fit cleanly into the earnings_release category (which typically covers quarterly/annual financial results) nor any other specific event type in the taxonomy, making other_material the most appropriate classification.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-05-27
Item 2.02
HEICO Corporation issued a press release on May 27, 2026 announcing results of operations for the three and six months ended April 30, 2026, disclosed under Item 2.02. This is a standard quarterly earnings release, which is material to investors as it provides financial performance data essential to assessing the registrant's operational and financial condition.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-05-27
Item 2.02
HP Inc. issued a news release on May 27, 2026 disclosing results of operations for its fiscal quarter ended April 30, 2026, with the release attached as Exhibit 99.1. This is a standard quarterly earnings disclosure, which is material to investors as it provides financial performance data essential to assessing the registrant's condition.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-05-27
Item 2.02
The filing discloses that Dycom Industries issued a press release on May 27, 2026 reporting fiscal 2027 first quarter results and provided forward guidance. The press release and related conference call materials are furnished as exhibits to the 8-K under Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for earnings releases. This is a material disclosure of quarterly financial results.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-27
Item 5.07
This is a clear Item 5.07 disclosure of shareholder voting results from UDR's Annual Meeting of Shareholders held on May 21, 2026. The filing reports final voting tallies for three proposals: election of eight directors (all elected), advisory approval of named executive officer compensation, and ratification of Ernst & Young LLP as independent auditor (all approved). The detailed vote counts for each director and proposal are the core content of the disclosure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-27
Item 5.07
This is a clear disclosure of shareholder vote results from ORI's Annual Meeting of Shareholders held on May 21, 2026. The filing presents final vote tallies for three proposals: election of directors (Proposals #1), ratification of KPMG LLP as independent auditor (Proposal #2), and advisory approval of executive compensation (Proposal #3), with detailed vote counts for each. This is a quintessential Item 5.07 disclosure and material to investors assessing corporate governance and management accountability.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-05-27
Item 5.02
The filing discloses the appointment of William Harkins to the role of Executive Vice President and Chief Financial Officer effective June 15, 2026, along with compensatory arrangements including a $610,000 base salary, bonus and equity adjustments, and a $500,000 one-time restricted stock award. While the filing also mentions Kenneth Krause's resignation as CFO, the principal disclosed action centers on Harkins' appointment to a senior executive role with material compensation details, making exec_appointment the most salient classification.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-05-27
Item 8.01
MYR Group Inc. entered into an agreement to acquire Valley Holdings I, Inc. and its subsidiaries for approximately $328.0 million in cash and borrowings, subject to regulatory approval and customary closing conditions. This material acquisition was announced via press release on May 27, 2026.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-05-27
Item 2.02
Bath & Body Works disclosed unaudited financial results for Q1 2026 and earnings guidance for Q2 2026 via press release on May 27, 2026, disclosed under Items 2.02 and 7.01.
View raw filing on EDGAR →
8-K
Exec departure
confidence 65%
filed 2026-05-27
Item 5.02
Eva C. Boratto, Chief Financial Officer and Chief Accounting Officer, resigned effective June 12, 2026, to pursue another professional opportunity. Tom Javitch was appointed as Interim CFO and D. Andrew Meeting as SVP Controller.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-05-27
Item 2.02
Mesa Laboratories issued a press release on May 27, 2026 disclosing financial results for the three and twelve months ended March 31, 2026, filed under Item 2.02 (Results of Operations and Financial Condition). This is a standard earnings release disclosure with the press release furnished as Exhibit 99.1, which is the typical format for quarterly/annual financial results reporting.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-27
Item 5.07
This is a classic Item 5.07 disclosure of shareholder meeting results. The filing reports voting outcomes for four proposals: election of nine directors, a say-on-pay advisory vote, ratification of Grant Thornton LLP as independent auditors, and approval of an amendment to the 2020 Omnibus Plan to increase available shares. All proposals passed with majority support. The disclosure is material as it confirms board composition and shareholder approval of executive compensation and equity plan amendments.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-27
Item 5.07
This is a clear disclosure of shareholder voting results from Ross Stores' Annual Meeting of Stockholders held on May 20, 2026. The filing presents final voting tallies for four proposals: election of 9 directors, approval of the 2026 Equity Incentive Plan, an advisory vote on executive compensation, and ratification of Deloitte & Touche LLP as independent auditor. This is a quintessential Item 5.07 disclosure and directly matches the shareholder_vote_results event type.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-27
Item 5.07
This is a clear disclosure of shareholder voting results from NextEra Energy's 2026 Annual Meeting of Shareholders held on May 21, 2026. The filing reports final voting tallies for five proposals: election of twelve board directors (Proposal 1), ratification of Deloitte & Touche LLP as auditor (Proposal 2), advisory vote on named executive officer compensation (Proposal 3), and two shareholder proposals on climate/Paris Agreement alignment (Proposals 4 and 5). This is a standard Item 5.07 disclosure of annual meeting results, which is material to investors as it reflects shareholder approval of governance and compensation matters.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-05-27
Item 1.01
This disclosure concerns Amendment No. 3 to a material acquisition agreement under which Unitil Corporation agreed to acquire all issued and outstanding shares of three water companies (Aquarion Water Company of Massachusetts, Inc., Aquarion Water Company of New Hampshire, Inc., and Abenaki Water Co., Inc.) from Aquarion Water Authority. The amendment extends the termination date from May 25, 2026 to June 30, 2026, representing a modification to an ongoing material acquisition transaction. Item 1.01 explicitly covers entry into material definitive agreements and amendments thereto related to acquisitions.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-27
Item 5.07
Sleep Number held its 2026 Annual Meeting with shareholder voting on seven proposals including director elections, board declassification amendments, auditor ratification, executive compensation advisory vote, and equity plan amendment. The equity plan amendment (increasing reserved shares by 750,000) and auditor ratification passed, while the board declassification and supermajority voting elimination proposals failed to achieve the requisite two-thirds vote.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-05-27
Item 5.02
The filing discloses the appointment of Stephen J. McAnena as President and Chief Executive Officer effective June 1, 2026, and the election of Tony DeSantis as a non-employee director. While the section also includes details on compensatory arrangements and a new Executive Severance Plan, the principal disclosed action centers on these executive and board appointments. The appointment of a new CEO is a material event that would affect a reasonable investor's assessment of the company's leadership and governance.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-05-27
Item 5.07
Trimble held its 2026 annual meeting of shareholders on May 26, 2026, with voting results disclosed for four proposals: director elections, say-on-pay advisory vote, auditor ratification, and ESPP amendments. The filing presents complete voting tallies including broker non-votes for each proposal.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-05-27
Item 8.01
Thomas Sweet was appointed by the Board as Chair of the Audit Committee, effective May 26, 2026. This appointment is material given its impact on governance and oversight of internal controls, particularly in light of the company's ongoing remediation of material weaknesses in internal control over financial reporting.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-27
Item 5.07
This is a classic Item 5.07 disclosure reporting the final results of Allstate's annual stockholders meeting held on May 22, 2026. The filing presents voting outcomes for four proposals: election of eleven directors, say-on-pay advisory vote, ratification of Deloitte & Touche LLP as independent auditor, and a shareholder proposal on ESG/DEI metrics in executive compensation. All results are presented with vote counts (For, Against, Abstain, Broker Non-Votes), which is the standard format for shareholder vote result disclosures.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-27
Item 8.01
The disclosure announces the pricing and remarketing of $15.0 million in revenue bonds with a new interest rate of 4.300% per annum for a 10-year period (June 1, 2026 to June 1, 2036). While this is a debt refinancing event, it does not fit neatly into the more specific categories (not a covenant breach, not a material impairment, not M&A activity). The mandatory tender and remarketing of existing debt at a new rate is a material financing event that would affect investor assessment of the company's capital structure and debt obligations, warranting disclosure as a material event under Item 8.01.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-05-27
The filing discloses results of an Annual Meeting of Shareholders held on May 26, 2026, under Item 5.07. The company reports voting results for two proposals: (1) election of nine directors for one-year terms, with detailed vote counts (For, Withheld, Broker Non-votes) for each director nominee, and (2) ratification of Crowe LLP as independent auditor. This is a standard shareholder vote results disclosure that materially informs investors of board composition and auditor approval.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-05-27
Item 1.01
EFCAR transferred a substantial portfolio of sub-prime automobile loan receivables (valued at approximately $384.41 million in aggregate note issuance) to a securitization trust structure in exchange for beneficial ownership interests, with secured financing through asset-backed notes issued by the Trust. This constitutes a material disposition of assets and entry into multiple definitive agreements governing the securitization transaction, which is a form of material acquisition/disposition activity reportable under Item 1.01.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-27
Item 5.07
This is a clear disclosure of shareholder vote results from TriNet's 2026 Annual Meeting of Stockholders held on May 27, 2026, covering three proposals: election of directors, advisory vote on named executive officer compensation, and ratification of the independent auditor (Deloitte & Touche LLP). The filing presents certified voting tallies for each proposal, which is the quintessential content of Item 5.07 shareholder_vote_results disclosures.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-27
Item 5.07
This is a clear disclosure of shareholder vote results from FS Bancorp's Annual Meeting held May 21, 2026, covering four proposals: election of directors (Terri L. Degner and Michael J. Mansfield), advisory vote on named executive officer compensation, adoption of the 2026 Equity Incentive Plan, and ratification of Baker Tilly US, LLP as independent auditor. All proposals passed with substantial majorities. This is a routine but material Item 5.07 disclosure required by SEC rules.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-27
Item 5.07
This Item 5.07 disclosure reports the final results of Orange County Bancorp's Annual Meeting of Stockholders held on May 26, 2026, including voting outcomes for director elections (Michael J. Gilfeather, Marianna R. Kennedy, and Richard B. Rowley) and ratification of Crowe LLP as independent auditor. All proposals were approved by stockholders, with specific vote tallies provided for each matter.
View raw filing on EDGAR →
8-K
Other material
confidence 45%
filed 2026-05-27
Item 8.01
The filing discloses a press release under Item 8.01 (Other Events) but provides no substantive detail about the press release's content. Without access to Exhibit 99.1, the specific event cannot be determined. Given Comcast's size and the formal 8-K filing, the event is likely material, but the event type cannot be reliably classified into a more specific category.
View raw filing on EDGAR →
8-K
Earnings release
confidence 99%
filed 2026-05-27
Item 2.02
Item 2.02 disclosure of first quarter financial results for the period ended April 30, 2026, with a press release attached as Exhibit 99.1. This is a standard earnings release announcement, which is material to investors as it provides periodic financial performance data.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-05-27
Item 2.02
The filing discloses unaudited financial results for Q1 ended May 2, 2026, via a news release attached as Exhibit 99.1. This is a classic earnings release disclosure under Item 2.02, which is material to investors as it provides quarterly operational and financial performance data.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-27
Item 8.01
The filing discloses conversion of a retail security pilot program into a long-term deployment for AITX's RAD product. While this represents a business development milestone that could be material to investors assessing the company's commercial traction and revenue prospects, the disclosure lacks specific financial metrics, contract terms, or quantified impact. The event does not fit neatly into the more specific taxonomy categories (not an earnings release, M&A activity, or material litigation), making "other_material" the most appropriate classification for this operational/commercial milestone.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 98%
filed 2026-05-27
Item 3.01
Medicus Pharma received written notice from Nasdaq on May 20, 2026, that it failed to meet the minimum Market Value of Listed Securities (MVLS) requirement of $35,000,000 for 30 consecutive business days and does not satisfy alternative listing standards. The company has 180 days until November 16, 2026, to regain compliance or face delisting.
View raw filing on EDGAR →
8-K
Other material
confidence 45%
filed 2026-05-27
Item 1.01
Medicus Pharma entered into a material definitive agreement creating a $22.864 million secured debt financing with embedded equity conversion features, including Note Exchange rights allowing conversion of the B Note into A Notes at a 2-to-1 formula and redemption rights tied to stock price and trading volume. The combination of debt and dilutive equity mechanics creates financial and capital structure implications.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-27
Item 5.07
This is a clear disclosure of shareholder meeting results under Item 5.07, reporting the outcomes of the 2026 Annual Meeting held on May 21, 2026. The filing presents voting results for two proposals: election of directors (Laila Partridge and Thomas Connelly, Jr.) and ratification of Stephano Slack LLP as independent auditor. These are routine but material governance matters that affect investor understanding of board composition and audit oversight.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-05-27
Item 2.02
Dick's Sporting Goods disclosed quarterly financial results for Q1 fiscal 2026, consistent with the May 27, 2026 filing date and the company's early-February fiscal year-end.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-05-27
Item 2.02
Agilent Technologies issued a press release on May 27, 2026 announcing financial results for the second fiscal quarter ended April 30, 2026.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-05-27
Item 5.02
Agilent appointed Tim Downs as Vice President, Chief Accounting Officer and principal accounting officer, effective May 20, 2026, following the retirement of Rodney Gonsalves.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-05-27
Item 3.02
The Company issued 6,924,700 unregistered shares of common stock as earn-out consideration under a stock purchase agreement, representing approximately 4.7% dilution to outstanding shares. The issuance was made pursuant to Section 4(a)(2) and Regulation D Rule 506(b) exemptions, with recipients holding restrictive legends and lock-up agreements. This is a material dilutive equity issuance properly disclosed under Item 3.02.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-27
Item 8.01
Apogee disclosed positive Phase 2 clinical trial results for zumilokibart (APG777) in atopic dermatitis, with the APEX Part B 16-week induction data meeting its primary endpoint (EASI-75) and key secondary endpoints across multiple dose cohorts with statistical significance (p<0.001) and a favorable safety profile, supporting advancement to Phase 3 development.
View raw filing on EDGAR →
8-K
M&A activity
confidence 85%
filed 2026-05-27
Item 1.01
Apogee entered into a material definitive agreement with Blackstone Life Sciences on May 26, 2026, under which BXLS purchased revenue participation rights in zumilokibart (APG777) in exchange for up to $650 million in staged funding. This material financing and revenue-sharing arrangement affects the company's capital structure and future cash flows.
View raw filing on EDGAR →